Literature DB >> 3460939

HLA-A and -B antigens in inflammatory bowel disease.

I Biemond, W R Burnham, J D'Amaro, M J Langman.   

Abstract

We examined all available data on HLA-A and -B antigen distributions in patients with Crohn's disease and ulcerative colitis. The risk of Crohn's disease was significantly increased in individuals with HLA-A2, having a relative risk of 1.25, in 730 pooled Caucasoid patients compared with 10 863 pooled controls, and decreased in individuals with HLA-A11, having a relative risk of 0.62. The risk of ulcerative colitis was also significantly increased in individuals with HLA-B27 and -Bw35, having a relative risk of 1.81 and 1.41 respectively, in 560 pooled Caucasoid patients compared with 6151 pooled controls, whilst in 144 pooled Japanese patients who were compared with 442 pooled controls, the risk of colitis was increased in individuals with HLA-B5 with a relative risk of 2.79. All differences remained significant after correction for the number of antigens examined. The bases for these genetic associations are unclear.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3460939      PMCID: PMC1433367          DOI: 10.1136/gut.27.8.934

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  19 in total

1.  Transplantation antigens in Crohn's disease: Linkage of associated ankylosing spondylitis with HL-Aw27.

Authors:  A S Russell; J S Percy; J Schlaut; V E Sartor; J M Goodhart; R W Sherbaniuk; E G Kidd
Journal:  Am J Dig Dis       Date:  1975-04

2.  Combined analysis of three studies of patients with Burkitt's lymphoma.

Authors:  J G Bodmer; W F Bodmer; P Pickbourne; L Degos; J Dausset; H M Dick
Journal:  Tissue Antigens       Date:  1975-02

3.  On estimating the relation between blood group and disease.

Authors:  B WOOLF
Journal:  Ann Hum Genet       Date:  1955-06       Impact factor: 1.670

4.  HLA antigens and ulcerative colitis in Japan.

Authors:  M Tsuchiya; T Yoshida; H Asakura; T Hibi; A Ono
Journal:  Digestion       Date:  1977       Impact factor: 3.216

5.  Histocompatibility antigens in inflammatory bowel disease. Their clinical significance and their association with arthropathy with special reference to HLA-B27 (W27).

Authors:  E G Mallas; P Mackintosh; P Asquith; W T Cooke
Journal:  Gut       Date:  1976-11       Impact factor: 23.059

6.  Proportion of disease caused or prevented by a given exposure, trait or intervention.

Authors:  O S Miettinen
Journal:  Am J Epidemiol       Date:  1974-05       Impact factor: 4.897

7.  HL-A frequencies in Crohn's disease and ulcerative colitis.

Authors:  L Bergman; J B Lindblom; J Säfwenberg; U Krause
Journal:  Tissue Antigens       Date:  1976-03

8.  HLA antigens in inflammatory bowel disease.

Authors:  J C Woodrow; R M Lewkonia; R B McConnell; E M Berg-Loonen; S G Meuwissen; B J Dekker-Saeys; L E Nijenhuis; J F Mowbray; N M Johnson
Journal:  Tissue Antigens       Date:  1978-02

9.  HLA antigens in ulcerative colitis and Crohn's disease in Israel.

Authors:  G Delpre; U Kadish; E Gazit; H Joshua; R Zamir
Journal:  Gastroenterology       Date:  1980-06       Impact factor: 22.682

10.  Controversy in human genetics. Blood groups and disease.

Authors:  A S Wiener
Journal:  Am J Hum Genet       Date:  1970-07       Impact factor: 11.025

View more
  16 in total

Review 1.  Are the inflammatory bowel diseases autoimmune disorders?

Authors:  J Snook
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

2.  Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.

Authors:  F Seibold; P Weber; R Klein; P A Berg; K H Wiedmann
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

3.  HLA class II genes in primary sclerosing cholangitis and chronic inflammatory bowel disease: no HLA-DRw52a association in Swedish patients with sclerosing cholangitis.

Authors:  H Zetterquist; U Broomé; K Einarsson; O Olerup
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

Review 4.  Immunosuppressive drugs in inflammatory bowel disease. A review of their mechanisms of efficacy and place in therapy.

Authors:  A B Hawthorne; C J Hawkey
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

Review 5.  Aetiology and pathogenesis of ulcerative colitis and Crohn's disease.

Authors:  D P Jewell
Journal:  Postgrad Med J       Date:  1989-10       Impact factor: 2.401

6.  Linkage of inflammatory bowel disease to human chromosome 6p.

Authors:  J Hampe; S H Shaw; R Saiz; N Leysens; A Lantermann; S Mascheretti; N J Lynch; A J MacPherson; S Bridger; S van Deventer; P Stokkers; P Morin; M M Mirza; A Forbes; J E Lennard-Jones; C G Mathew; M E Curran; S Schreiber
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

7.  MHC class I chain-related gene A-A5.1 allele is associated with ulcerative colitis in Chinese population.

Authors:  Yijuan Ding; Bing Xia; Min Lü; Yan Zhang; Jin Li; Mei Ye; Hesheng Luo; Jieping Yu; Xiaolian Zhang; Jingquan Tan
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

8.  Genetics of inflammatory bowel disease.

Authors:  J Satsangi; D P Jewell; W M Rosenberg; J I Bell
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

9.  Crohn's disease: the genetic contribution.

Authors:  J Sofaer
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

10.  A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort.

Authors:  J Hampe; S Schreiber; S H Shaw; K F Lau; S Bridger; A J Macpherson; L R Cardon; H Sakul; T J Harris; A Buckler; J Hall; P Stokkers; S J van Deventer; P Nürnberg; M M Mirza; J C Lee; J E Lennard-Jones; C G Mathew; M E Curran
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.